Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy.

MLA

Ye-Ping Ma, et al. “Angiotensin II Type 1 Receptor Blockers Favorably Affect Renal Angiotensin II and MAS Receptor Expression in Patients with Diabetic Nephropathy.” Journal of the Renin-Angiotensin-Aldosterone System, vol. 21, no. 2, Apr. 2020, pp. 1–7. EBSCOhost, https://doi.org/10.1177/1470320320919607.

APA

Ye-Ping Ma, Yue Yang, Shi-Min Jiang, Lin Liu, Zheng Zhang, Yi-Ning Wang, Gu-Ming Zou, Wen-Ge Li, Ma, Y.-P., Yang, Y., Jiang, S.-M., Liu, L., Zhang, Z., Wang, Y.-N., Zou, G.-M., & Li, W.-G. (2020). Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy. Journal of the Renin-Angiotensin-Aldosterone System, 21(2), 1–7. https://doi.org/10.1177/1470320320919607

Chicago

Ye-Ping Ma, Yue Yang, Shi-Min Jiang, Lin Liu, Zheng Zhang, Yi-Ning Wang, Gu-Ming Zou, et al. 2020. “Angiotensin II Type 1 Receptor Blockers Favorably Affect Renal Angiotensin II and MAS Receptor Expression in Patients with Diabetic Nephropathy.” Journal of the Renin-Angiotensin-Aldosterone System 21 (2): 1–7. doi:10.1177/1470320320919607.